SUBSCRIBE
SUBSCRIBE

Juno Therapeutics

NEWS
Juno Therapeutics was acquired by Bristol-Myers Squibb in 2019.
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Juno Therapeutics Post IPO: Ups and Downs But Mostly Ups
March 17, 2015
 · 
3 min read
Job Trends
Juno Therapeutics CEO and CFO Earn Hefty Bonuses; Poaches Ex-Amgen, Dendreon Scientists
February 25, 2015
 · 
3 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Job Trends
Booming Juno Therapeutics to Boost Headcount With New Manufacturing Site in Washington
February 9, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Juno Therapeutics CEO Eyes New Commercial Immunotherapy Treatment Facility for 2015
January 14, 2015
 · 
2 min read
J.P. Morgan: AstraZeneca CEO Says He's Not Worried About Pricing Pressure
Drug Development
J.P. Morgan: Juno Therapeutics Touts 10 New Drugs for Six Diseases, Loves New CAR-T Platform
January 14, 2015
 · 
3 min read
Biotech Bay
Reasons Juno Therapeutics Is The Biotech Of The Year
January 5, 2015
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Juno Therapeutics CEO Pockets $100 Million in IPO; Largest Investor Makes $1 Billion
December 23, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Amazon.com-Backed Juno Therapeutics Aims Even Higher; Eyes $212 Million IPO
December 16, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Lucky Juno Therapeutics Sets Terms For Biggest IPO Of 2014: $191 Million
December 9, 2014
 · 
1 min read
Load More
AWARDS
  • NextGen Class of 2015
JOBS
IN THE PRESS
BioForest
Already-Rich Juno Therapeutics Reels In Another $134 Million, Has Raised $300 Million In Less Than 12 Months
August 5, 2014
 · 
2 min read
BioForest
Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round
April 24, 2014
 · 
4 min read
Pharm Country
Clinical Trial Of Juno Therapeutics Cell Therapy Restarts
April 21, 2014
 · 
1 min read
Drug Development
Seattle’s Juno Therapeutics Pauses Trial After Patient Deaths
April 9, 2014
 · 
1 min read
Business
Juno Therapeutics Appoints Biotech Investment Banking Leader Steve Harr As CFO And Head Of Corporate Development
March 31, 2014
 · 
2 min read
Business
Cellectis, Servier Forge Leukemia, Solid Tumors Pact To Battle With Novartis AG And Newbie Juno Therapeutics
February 18, 2014
 · 
4 min read
BioForest
Already-Rich Startup, Juno Therapeutics, Expands Series A Funding Round To $145 Million
January 14, 2014
 · 
1 min read
BioForest
Biotech Startup, Juno Therapeutics, Grabs $120 Million To Coax Immune System To Fight Cancer
December 4, 2013
 · 
1 min read
Load More